Keith Cannon joins the AVIVA Biosciences management team, bringing nearly 20 years experience in sales, marketing, and strategy. Keith will take the role of Executive Vice President and Director of Sales at Aviva.
“This is an exciting new role for me to leverage my leadership and commercialization skills – AVIVA has a new technology for processing and enriching nucleated cells from blood. It’s a great opportunity to build a platform for the Red Sift filter array technology and introduce to the market.”
“At the same time, I will run the existing business for pharmaceutical services for ion channel safety assessment, and we manufacture the sealchip device for patch clamp applications.”
Aviva Biosciences has a legacy of applying physical and biological properties to develop valuable tools for biomedical research, drug efficacy and medical diagnostics.
Keith Cannon joins AVIVA Biosciences as Executive Vice President, to lead effort to commercialize new instrument platform
← Back to Previous Page